Swedeheart variabellista
SpletThe VALIDATE-SWEDEHEART trial was a registry-based randomized trial comparing bivalirudin and heparin for patients who underwent percutaneous coronary intervention without planned glycoprotein IIb/IIIa inhibitors after acute myocardial infarction.4 It showed no differences in the composite endpoint at 180 days, which included death from any ... Splet20. maj 2024 · An observational SWEDEHEART study 17 that included patients from January 2007 to December 2014 and all percutaneous coronary intervention conducted in Sweden found significantly higher 30-day mortality in the heparin group in the adjusted analysis but not in the propensity-matched analysis. 17 The VALIDATE-SWEDEHEART …
Swedeheart variabellista
Did you know?
SpletVariabellista med specifikation av vilka personuppgifter som begärs ut för forskningsändamål. Regionen har inget specifikt krav på filformat för variabellistan, utan kan med fördel skickas in som till exempel word eller excelfil. Den kompletta ansökan mailas därefter till: [email protected] Splet16. avg. 2024 · According to the study authors, these results were consistent across patients with STEMI and NSTEMI, as well as other major subgroups. Broken down by event, MI occurred in 2.0 percent of patients in the bivalirudin group, compared to 2.4 percent in the heparin group (P=0.33); major bleeding occurred in 8.6 percent of patients in both …
SpletAssessing the external validity of the VALIDATE-SWEDEHEART trial The propensity score difference demonstrated that the screened not-enrolled with fulfilled inclusion criteria … SpletStart - SWEDEHEART Senaste nytt Uppdaterade variabellistor samt uppdaterade manualer Fysioterapi Uppdaterade formulär 2024 Formulär för Psykisk Hälsa uppdaterat Pågående …
Splet24. sep. 2024 · Detailed Description: The Infinity-Swedeheart trial is a prospective, multicenter, single-blind, randomized registry-based clinical trial. Eligible patients will be randomized 1:1 (DynamX Bioadaptor : Resolute Onyx). 2400 Patients will be … Splet20. maj 2024 · Uppsala University Abstract and Figures Aims The VALIDATE-SWEDEHEART trial was a registry-based randomized trial comparing bivalirudin and heparin in patients with acute myocardial infarction...
Splet01. sep. 2024 · Det europeiska kardiologisällskapet ESC har beslutat att bygga ett gemensamt europeiskt kvalitetsregister för hjärtsjukdomar. Det inspireras av och kommer till betydande del bygga på de svenska registren i Swedeheart. Ämnen i artikeln: ESC Hjärtsvikt Hjärtinfarkt Förmaksflimmer Carl-Magnus Hake carl …
Splet20. mar. 2024 · Methods: We retrospectively analysed adult patients with first-presentation ST-elevation myocardial infarction (STEMI) using data from the Swedish myocardial infarction registry SWEDEHEART. Clinical characteristics and outcomes of adult patients (age ≥18 years) with and without SMuRFs were examined overall and by sex. phil harris \u0026 alice faye radio showSplet27. avg. 2024 · In summary, VALIDATE-SWEDEHEART was a registry-based, randomized, controlled trial that compared bivalirudin with heparin monotherapy among patients with … phil harris\u0027s child phyllis wanda harrisSplet03. dec. 2024 · The results of iFR-SWEDEHEART provide preliminary evidence that iFR is a viable alternative to FFR as a means of determining physiological significance of epicardial coronary stenoses, with similar clinical event rates using either approach. iFR also has the added benefit of avoiding the use of adenosine, which results in a much lower frequency ... phil harris the thing videoSplet2 - SWEDEHEART Public Report 2024 (Swedish)1653 Nedladdningar10.97 MB. phil harropSpletAssessing the external validity of the VALIDATE-SWEDEHEART trial The propensity score difference demonstrated that the screened not-enrolled with fulfilled inclusion criteria and trial population were not similar. The inverse-probability weighted analysis showed no significant differences in mortality. phil harris \u0026 alice fayeSplet31. jan. 2024 · Submitted Nov 14, 2024. Accepted for publication Nov 20, 2024. doi: 10.21037/jtd.2024.11.126 phil harrop mercyoneSpletStudy design and objectives: The SWITCH SWEDEHEART trial is a prospective, multicenter, open-label, cross-sectional, stepped-wedge cluster-randomized clinical trial, in which administrative regions in Sweden will constitute the clusters. At the start of the study, all clusters will use ticagrelor as the P2Y12 inhibitor drug of choice for ACS. phil harris\u0027s son jake harris